|
🐜
|
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial
23 auth.
M. Jongsma,
M. Aardoom,
M. Cozijnsen,
M. van Pieterson,
T. D. de Meij,
M. Groeneweg,
O. Norbruis,
V. Wolters,
H. V. van Wering,
I. Hojsak,
...
K. Kolho,
T. Hummel,
J. Stapelbroek,
C. van der Feen,
P. V. van Rheenen,
M. V. van Wijk,
Sarah T A Teklenburg-Roord,
M. Schreurs,
D. Rizopoulos,
M. Doukas,
J. Escher,
J. Samsom,
L. de Ridder
|
6 |
2020 |
6
🐜
|
|
🐜
|
Gut-directed hypnotherapy versus standard medical treatment for nausea in children with functional nausea or functional dyspepsia: protocol of a multicentre randomised trial
15 auth.
P. Browne,
B. den Hollander,
Esther M Speksnijder,
H. V. van Wering,
W. E. Tjon a Ten,
E. George,
M. Groeneweg,
N. Bevers,
Margaretha M S Wessels,
M. M. van den Berg,
...
J. Goede,
Sarah T A Teklenburg-Roord,
C. Frankenhuis,
M. Benninga,
A. Vlieger
|
3 |
2019 |
3
🐜
|
|
🐜
|
Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn’s disease
15 auth.
M. Jongsma,
S. Vuijk,
M. Cozijnsen,
M. van Pieterson,
O. Norbruis,
M. Groeneweg,
V. Wolters,
H. V. van Wering,
I. Hojsak,
K. Kolho,
...
M. V. van Wijk,
Sarah T A Teklenburg-Roord,
T. D. de Meij,
J. Escher,
L. de Ridder
|
2 |
2022 |
2
🐜
|
|
🐜
|
OP38 Top-down infliximab superior to step-up in children with Moderate-to-Severe Crohn’s disease: A multicentre randomised controlled trial
19 auth.
M. Jongsma,
M. Aardoom,
M. Cozijnsen,
T. Meij,
O. Norbruis,
M. Groeneweg,
V. Wolters,
H. V. Wering,
I. Hojsak,
K. Kolho,
...
T. Hummel,
J. Stapelbroek,
C. V. D. Feen,
P. Rheenen,
M. V. Wijk,
Sarah T A Teklenburg-Roord,
J. Escher,
J. Samsom,
L. Ridder
|
1 |
2020 |
1
🐜
|
|
🐜
|
Fatigue and Physical Activity Patterns in Children With Inflammatory Bowel Disease
17 auth.
N. Bevers,
E. van de Vijver,
Adrienne Hanssen,
Arta Aliu,
S. Vande Velde,
E. Roelant,
A. Rezazadeh Ardabili,
P. Rosias,
J. Stapelbroek,
Imke Bertrams Maartens,
...
C. van de Feen,
J. Escher,
A. Oudshoorn,
Sarah T A Teklenburg-Roord,
A. Vreugdenhil,
M. Pierik,
P. V. van Rheenen
|
1 |
2023 |
1
🐜
|
|
🐜
|
University of Groningen First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial
23 auth.
M. Jongsma,
M. Aardoom,
M. Cozijnsen,
M. V. Pieterson,
T. Meij,
M. Groeneweg,
O. Norbruis,
V. Wolters,
H. V. Wering,
I. Hojsak,
...
K. Kolho,
T. Hummel,
J. Stapelbroek,
C. V. D. Feen,
P. Rheenen,
M. P. Wijk,
Sarah T A Teklenburg-Roord,
M. Schreurs,
D. Rizopoulos,
M. Doukas,
J. Escher,
J. Samsom,
L. Ridder
|
0 |
2021 |
0
🐜
|
